Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

22
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
22
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

40
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
40
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

34
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
34
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

22
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
22

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

"Everyone's Responsibility and No-One's Responsibility": A Thematic Analysis of a Roundtable on the Complex Problem of Secondary Stroke Prevention in Australia.

Health expectations : an international journal of public participation in health care and health policy·2026
Same author

Early Cerebral Edema Subtypes and Functional Outcome in Patients With Cerebral Venous Thrombosis: Insights From the CLOT-VENUS Registry.

Neurology·2026
Same author

Glycemic control and clinical outcomes in patients with diabetes and atrial fibrillation: a nationwide cohort study.

Acta diabetologica·2026
Same author

Early versus Late starting of Direct Oral Anticoagulants after breakthrough ischemic stroke: A Target Trial Analysis from the ASPERA-R Study.

International journal of stroke : official journal of the International Stroke Society·2026
Same author

Gout and Risk of Ischemic Stroke in Patients With Atrial Fibrillation: A Nationwide Cohort Study.

Stroke·2026
Same author

Inflammation induced by snake venoms optimizes envenomation.

The Journal of physiology·2026

Related Experiment Video

Updated: Sep 9, 2025

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations
14:58

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations

Published on: October 20, 2017

9.8K

Mortality After Cerebral Venous Thrombosis.

Elisa Häppölä1, Sini Hiltunen1, Erik Lindgren2,3

  • 1Department of Neurology, Helsinki University Hospital and University of Helsinki, Finland.

Neurology
|September 2, 2025
PubMed
Summary

Early mortality in cerebral venous thrombosis (CVT) is low, but cancer significantly impacts long-term survival. This study identified key predictors for both early and late death in CVT patients, offering insights for improved patient outcomes.

More Related Videos

A Low Mortality Rat Model to Assess Delayed Cerebral Vasospasm After Experimental Subarachnoid Hemorrhage
07:03

A Low Mortality Rat Model to Assess Delayed Cerebral Vasospasm After Experimental Subarachnoid Hemorrhage

Published on: January 17, 2013

14.4K
A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
06:01

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

Published on: August 18, 2015

15.0K

Related Experiment Videos

Last Updated: Sep 9, 2025

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations
14:58

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations

Published on: October 20, 2017

9.8K
A Low Mortality Rat Model to Assess Delayed Cerebral Vasospasm After Experimental Subarachnoid Hemorrhage
07:03

A Low Mortality Rat Model to Assess Delayed Cerebral Vasospasm After Experimental Subarachnoid Hemorrhage

Published on: January 17, 2013

14.4K
A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
06:01

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

Published on: August 18, 2015

15.0K

Area of Science:

  • Neurology
  • Vascular Medicine
  • Oncology

Background:

  • Cerebral venous thrombosis (CVT) historically carried a poor prognosis.
  • Recent diagnostic and therapeutic advancements may have improved patient outcomes.
  • International data is crucial for understanding CVT mortality trends.

Purpose of the Study:

  • To evaluate mortality rates and causes of death in patients with CVT.
  • To identify predictors of early (30-day) and late (1-year) mortality in CVT.
  • To assess the impact of cancer on long-term CVT outcomes.

Main Methods:

  • Multicenter cohort study of 1,525 adult CVT patients (1995-2021).
  • Assessment of mortality within 30 days and between 31-365 days post-diagnosis.
  • Cox regression analysis to determine predictors of death.

Main Results:

  • Overall one-year mortality was 5.6% (early: 3.4%).
  • Leading early death causes: intracerebral hemorrhage (ICH)/herniation (48.1%), cancer (21.2%).
  • Leading late death causes: cancer (38.2%), ICH/herniation (23.5%), infection (17.6%).
  • Early death predictors: coma, cancer, age >55, ICH/herniation, nonparenchymal hemorrhage.
  • Late death predictors: cancer, age >55, absence of female-specific risk factors.

Conclusions:

  • Early mortality in CVT is low and consistent with prior research.
  • Cancer is the predominant cause of late mortality in CVT patients.
  • Understanding these mortality predictors can guide clinical management and improve long-term prognosis.